Level of Serum Lactate Dehydrogenase in Immune Thrombocytopenia

Assessment of relation between serum lactate dehydrogenase and immune thrombocytopenia

Not Yet Recruiting

Trial opening soon.

Key information

Conditions

Immune Thrombocytopenia (ITP) Autoimmune Diseases Blood Coagulation Disorders Blood Platelet Disorders Cytopenia Hematologic Diseases Hemic and Lymphatic Diseases Hemorrhage Hemorrhagic Disorders Immune System Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms Purpura Purpura, Thrombocytopenic Purpura, Thrombocytopenic, Idiopathic Signs and Symptoms Skin Manifestations Thrombocytopenia Thrombotic Microangiopathies

Age range

16 year and older

Sex eligibility

All sexes

Study type

Observational

About this study

Immune thrombocytopenia is an autoimmune disorder defined by a significantly reduced number of platelets in blood circulation.

Lactate dehydrogenase is a group of oxidoreductase isoenzymes catalyzing the reversible reaction between pyruvate and lactate.

The LDH was found to be moderately high in patients with immune thrombocytopenia at the time of diagnosis.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Thrombocytopenia patients at the time of diagnosis.

Exclusion criteria

bone fractures _ bone diseases_ malignancy

Treatment and study plan

Lactate dehydrogenase

Diagnostic Test

It's elevation at the time of diagnosis

Primary outcomes

Relation between serum lactate dehydrogenase and immune thrombocytopenia

Time frame: About 2 years

Study contacts

Contact information is provided by the study sponsor or research team.

Hassnaa Ahmed Abo elwafa, Prof.Dr

CONTACT

Shaimaa Mahmoud Fahmy, Resident doctor

CONTACT

[email protected]

01149586292

Sponsors and collaborators

Lead sponsor

Sohag University

Other

Registry information

Official study title

Relation Between Serum Lactate Dehydrogenase and Immune Thrombocytopenia

Important dates

Study start: 2025
Primary completion: 2027
Study completion: 2027
First posted: Jul 1, 2025
Registry last updated: Jul 1, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Not Yet Recruiting